Peak Pharmaceutical has another postdoctoral entrance to open the topic.
Release time:
2023-06-25
On the afternoon of June 15, the post-doctoral research station of Jianfeng Pharmaceutical held a review meeting for Dr. Wu Zhuo from Donghua University.
Dr. Wu Zhuo's main research directions are research and development of new cardiovascular and cerebrovascular drugs, total synthesis of natural products, and organic synthesis technology. He has published more than ten papers in internationally renowned academic journals such as Eur. J. Med. Chem, and has won many excellent papers awards at the annual meeting of microbiology and biochemical drugs of Shanghai Pharmaceutical Association. Dr. Wu Zhuo's research project in the post-doctoral research station of Jianfeng Pharmaceutical is entitled "Design, synthesis and anti-tumor mechanism of oxindole compounds based on p53 target". At the opening review meeting, he elaborated on the background of the research project, the significance of the topic, the key problems to be solved, the solution plan, the main technical difficulties and innovation points, the work schedule and the budget, and accepted the questions and comments of the expert group.
The expert group of the opening review meeting is headed by Professor Chen Zhilong of Donghua University. Its members include Professor Wu Fanhong of Shanghai University of Applied Technology, Professor Fang Weijie of Zhejiang University's School of Pharmacy, Professor Jin Zhunian of Jinhua Vocational and Technical College of Pharmacy and Dr. Zhang Qiang, chief scientist of Jianfeng Pharmaceutical. Among them, Professor Chen Zhilong and Dr. Zhang Qiang will serve as Dr. Wu Zhuo's on-site co-site mentors respectively. Leaders of Jinhua Human Resources and Social Security Bureau, Science and Technology Bureau, Jinhua Development Zone Organization Human Resources and Social Security Bureau and other relevant departments, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, also attended the meeting. Jiang Xiaomeng, the host of the
opening review meeting, expressed his heartfelt thanks to all the leading experts for their arrival, and briefly introduced the development process of Jianfeng Pharmaceutical, and affirmed the work achievements of the postdoctoral workstation that has been rated as an excellent workstation for many years. He believes that Dr. Wu Zhuo's inbound research project has scientific significance and application value, and expects the research project to achieve the desired results. Huang Jinlong said that the P53 target is an important anti-cancer target that is currently being focused on at home and abroad. It is believed that with the continuous deepening of the research on this target, it will play a positive role in promoting the research and application of anti-cancer drugs. The company will fully support the research of this subject, provide all-round protection in terms of talents, equipment, funds, etc., and require Dr. Zhang Qiang to spend more energy to guide and participate in project research, I look forward to the early results and the early completion of the project.
After discussion, the expert group believed that Dr. Wu Zhuo's research project was selected appropriately, based on sufficient basis, with clear objectives and requirements, and the design scheme was feasible. He himself was capable of undertaking the research of the subject, and the relevant funds and schedule were reasonable. He agreed to open the topic. (Zhu Ningyan)
More information
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-22
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-30
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
Chairman Jiang Xiaomeng Directs Work in Yunnan Peak
On December 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, went to Yunnan Jianfeng cement company to investigate and guide the work. On the morning of the same day, accompanied by the Yunnan peak management team, Jiang Xiaomeng went deep into the front line and successively went to the central control room of the production and manufacturing department, the raw material clay yard, the lignite yard and other areas for field investigation and investigation to understand the problems existing in the production and operation process. Subsequently, a business analysis meeting was held to make a comparative analysis of the various business indicators of Yunnan Jianfeng from January to November this year, and put forward two requirements to the management team: further strengthen internal management and improve execution; strengthen the coordination of external relations, and improve The ability and level of enterprise resource acquisition. At the Yunnan Jianfeng middle-level cadre meeting held on the afternoon of the 16th, Jiang Xiaomeng first fully affirmed Yunnan Jianfeng's highest output and best benefits since it was put into production in 2018, and expressed his gratitude to all cadres and employees of Yunnan Jianfeng for their hard work. After that, Jiang Xiaomeng made a detailed analysis of the cement industry and the regional market environment in Yunnan, and combined with the current production and operation situation of Yunnan Jianfeng, put forward the focus of the next step: 1. should fully attach importance to and mobilize the initiative and responsibility of employees at all levels to improve the overall execution of the team; 2. raw material mines are an important factor restricting the future development of cement enterprises, which should be paid full attention to and formulate clear strategies and methods, set out a timetable to obtain future production resources as much as possible; 3. continuously advocate and promote technological innovation, keep pace with the times, continuously improve production management, equipment management, production technology level, and maintain the competitive advantage of the industry; 4. further strengthen production
2020
07-31